Daniel Shore
About Daniel Shore
Daniel Shore is a Senior Scientist specializing in Medicinal Chemistry at ORIC Pharmaceuticals Inc., where he has worked since 2022. He has extensive experience in the field, having previously held positions at Genentech, Gilead Sciences, and ORIC Pharmaceuticals.
Current Role at ORIC Pharmaceuticals
Daniel Shore currently serves as a Senior Scientist in Medicinal Chemistry at ORIC Pharmaceuticals Inc. He has held this position since 2022, contributing to the company's research and development efforts in South San Francisco, California. In this role, he applies his extensive knowledge in medicinal chemistry to advance the company's drug discovery projects.
Previous Experience at ORIC Pharmaceuticals
Before his current role, Daniel worked at ORIC Pharmaceuticals Inc. as a Scientist in Medicinal Chemistry from 2021 to 2022. During this year, he focused on various projects aimed at developing new therapeutic candidates, leveraging his expertise in the field.
Professional Background in Medicinal Chemistry
Daniel has a robust background in medicinal chemistry, having worked at several prominent organizations. He was a Senior Research Associate II at Gilead Sciences from 2019 to 2021 and held multiple positions at Genentech, including Senior Scientific Researcher and Research Associate in Discovery Chemistry from 2009 to 2019. His experience spans over a decade in the pharmaceutical industry, emphasizing drug discovery and development.
Educational Qualifications
Daniel Shore obtained a Bachelor of Science in Chemistry from the University of Ottawa, where he studied from 2003 to 2007. He furthered his education with a Master of Science in Organic Chemistry at the same institution, completing his studies from 2007 to 2009. His academic background provides a strong foundation for his work in medicinal chemistry.
Early Career Experience
Daniel began his career with a summer internship at Merck-Frosst in 2007. He later gained significant experience at Genentech, where he worked for six years as a Research Associate and then as a Senior Research Associate in Discovery Chemistry. This early experience laid the groundwork for his subsequent roles in the pharmaceutical industry.